EC Number   |
Ki Value [mM] |
Ki Value maximum [mM] |
Inhibitor |
Reference |
|---|
   3.4.21.109 | -999 |
- |
more |
- |
683753 |
| 3.4.21.109 | -999 |
- |
more |
inhibition kinetics with antobodies E2 and S4 and point mutants thereof, overview |
683778 |
| 3.4.21.109 | 0.000000011 |
- |
L-arginyl-N1-[(2S)-1-[[(2S)-1-(1,3-benzothiazol-2-yl)-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]-L-glutamamide |
matriptase, pH and temperature not specified in the publication |
731040 |
| 3.4.21.109 | 0.0000000123 |
- |
scFv antibody E2 |
- |
683778 |
| 3.4.21.109 | 0.0000000497 |
- |
Bovine pancreatic trypsin inhibitor |
- |
683778 |
| 3.4.21.109 | 0.0000000704 |
- |
scFv antibody S4 |
- |
683778 |
| 3.4.21.109 | 0.00000008 |
- |
3-[(2S)-3-[4-(2-aminoethyl)piperidin-1-yl]-2-([[3-(6-amino-2,3,4,5-tetrahydropyridin-3-yl)phenyl]sulfonyl]amino)-3-oxopropyl]benzenecarboximidamide |
- |
696696 |
| 3.4.21.109 | 0.000000088 |
- |
N1-[(2S)-1-[[(2S)-1-(1,3-benzothiazol-2-yl)-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]-L-glutamamide |
matriptase, pH and temperature not specified in the publication |
731040 |
| 3.4.21.109 | 0.0000001 |
- |
3-[(2S)-3-[4-(2-aminoethyl)piperidin-1-yl]-2-([[3-(6-amino-2,3,4,5-tetrahydropyridin-3-yl)phenyl]sulfonyl]amino)-3-oxopropyl]benzenecarboximidamide |
- |
708791 |
| 3.4.21.109 | 0.00000013 |
- |
9-fluorenylmethyloxycarbonyl-GR-ketobenzothiazole |
pH not specified in the publication, temperature not specified in the publication |
754402 |
